Financial information

All

Business

CSR

Event

Financial information

Group

Innovation

Neuroscience

Oncology

Patient

People

Rare diseases

22 results

Financial information

Ipsen – 2019 Q3 results – October 24, 2019 at 2:30pm CEST

24 October 2019

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

q3-2019-presentation.pdf

Financial information

Ipsen will hold a conference call Thursday, 25 July 2018 at ...

18 July 2019

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Event

Ipsen – Investor Day 2019

13 May 2019

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen – 2019 First Quarter results – April 24, 2...

23 April 2019

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

q1-2019-sales.pdf

Financial information

Ipsen reiterated its commitment to the Innobio-2 fund

06 February 2019

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen – Half Year 2018 Results Conference Call – Thursday, J...

02 July 2018

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

h1-2018-presentation-final11.pdf

Financial information

Ipsen’s Full Year 2017 Financial Results

14 February 2018

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen delivers strong sales growth of 22.6% for the third qu...

19 December 2017

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen’s First Half 2017 Financial Results

25 July 2017

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen’s 2016 Full Year Results

09 February 2017

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

1
2

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023